|
gptkbp:instanceOf
|
Controlled substance category
|
|
gptkbp:example
|
gptkb:Alprazolam
gptkb:Clonazepam
gptkb:Diazepam
gptkb:Lorazepam
gptkb:Phenobarbital
gptkb:Tramadol
gptkb:Zolpidem
gptkb:Propofol
gptkb:Butorphanol
gptkb:Clobazam
gptkb:Modafinil
gptkb:Pentazocine
gptkb:Quazepam
gptkb:Suvorexant
gptkb:Clorazepate
gptkb:Halazepam
gptkb:Oxazepam
gptkb:Carisoprodol
gptkb:Eszopiclone
gptkb:Zaleplon
gptkb:Zopiclone
gptkb:Chlordiazepoxide
gptkb:Midazolam
gptkb:Temazepam
gptkb:Chloral_hydrate
gptkb:Meprobamate
Armodafinil
Benzphetamine
Butabarbital
Daridorexant
Diethylpropion
Difenoxin
Eluxadoline
Estazolam
Ethchlorvynol
Fenfluramine
Flurazepam
Lemborexant
Lorcaserin
Mazindol
Metharbital
Pemoline
Phentermine
Remimazolam
Sibutramine
Triazolam
|
|
gptkbp:hasAcceptedMedicalUse
|
gptkb:United_States
|
|
gptkbp:hasLowerAbusePotentialThan
|
gptkb:Schedule_III_substances
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule IV substances
|
|
gptkbp:partOf
|
gptkb:Controlled_Substances_Act_(United_States)
|
|
gptkbp:regulates
|
gptkb:Drug_Enforcement_Administration
|
|
gptkbp:bfsParent
|
gptkb:21_U.S.C._§_812
gptkb:21_U.S.C._§_841
gptkb:21_U.S._Code_§_829
gptkb:21_U.S._Code_§_841
|
|
gptkbp:bfsLayer
|
7
|